BeiGene and ZJU Ruiyi Haining Establish Joint Innovation Center to Advance AI-Driven Healthcare Solutions for County-Level Medical Consortia

Today, BeOne Medicines announced the establishment of the “BeOne Medicines–Zhejiang University Ruiyi Haining Joint Innovation Center” in collaboration with the Zhejiang University Ruiyi Haining Artificial Intelligence Research Center. The partnership is dedicated to advancing the informatization and intelligent development of county-level medical consortia, strengthening the clinical application of scientific and technological innovations in oncology and other related medical fields, and creating innovative healthcare solutions for diverse scenarios through new concepts and technologies.

Group Photo at the Signing Ceremony

As the national tiered diagnosis and treatment system continues to deepen, the National Health Commission has been strengthening the specialization and informatization of county-level hospitals. In active response to national policies, the Zhejiang Provincial Health Commission took the lead in launching the construction of “Demonstration Counties for Informatization of Medical Consortia” and “Demonstration Centers for Innovative Applications of Medical Artificial Intelligence” across the province, better empowering county-level healthcare services with new concepts and technologies to enhance patients’ diagnostic and treatment experiences.

Address by Peng Linjun, Member of the Standing Committee of the Haining Municipal Party Committee and Head of its Organization Department

Peng Linjun, Member of the Standing Committee of the Haining Municipal Party Committee and Head of the Organization Department, stated, “This collaboration not only exemplifies the successful attraction of high-quality projects and the recruitment and development of top-tier talent for the Science and Technology City, but also fully demonstrates Haining City’s firm determination and confidence in developing the life and health industry. In the future, we will further provide robust resource support to the life and health industry, attracting more enterprises and innovative projects.”

Address by Wu Jian, Director of the Haining Research Center of Zhejiang University’s Ruiyi Medical

Dr. Wu Jian, Director of the Zhejiang University RYI Haining Research Center, stated, “Zhejiang University RYI and BeOne Medicines have maintained a strong partnership in the field of intelligent healthcare innovation. The establishment of this Joint Innovation Center will facilitate the development of a more diverse portfolio of products based on medical big data and artificial intelligence, driving the advancement of intelligent healthcare through application-oriented approaches and empowering county-level medical services with more intelligent solutions.”

Remarks by Wu Qingyi, Senior Vice President and Chief Commercial Officer, Greater China, at BeOne Medicines

Wu Qingyi, Senior Vice President and Chief Commercial Officer of Greater China at BeOne Medicines, stated in her address: “BeOne Medicines is actively supporting Haining in establishing itself as a ‘Demonstration County for Informatics Construction in Medical Consortia and Demonstration Center for Innovative Applications of Medical Artificial Intelligence,’ with plans to gradually extend this model to primary healthcare institutions across all county-level regions in China. In future market promotion efforts, we will further collaborate with the Haining Artificial Intelligence Research Center of Zhejiang University’s Ruiyi Medical to jointly establish the ‘BeOne Medicines–Zhejiang University Ruiyi Medical Haining Joint Innovation Center,’ thereby accelerating the industrial translation and promotion of intelligent technological achievements and actively empowering oncology diagnosis and treatment services in county-level regions.”

Technology-Driven Innovation: BeOne Medicines Aims to Contribute More Resources and Innovative Strength to Enhance China’s Healthcare Standards. Upon the establishment of the BeOne Medicines–Zhejiang University Ruiyi Haining Joint Innovation Center, we will continuously identify typical best practices and distinctive approaches, strengthen the summarization of experience, and promote achievements nationwide. In the future, we will invite healthcare professionals from county-level regions across China to visit and learn from Haining’s leading experiences in medical informatization and intelligent construction, conduct training on innovative technologies and management models, and assist county-level medical institutions in leveraging intelligent tools to implement cancer-related public health initiatives.